Literature DB >> 25726707

Nosocomial bloodstream infections in a nationwide study: comparison between solid organ transplant patients and the general population.

L F A Camargo1, A R Marra, A C C Pignatari, T Sukiennik, P P P Behar, E A S Medeiros, J Ribeiro, E Girão, L Correa, C Guerra, C Brites, C A P Pereira, I Carneiro, M Reis, M A Souza, C U Barata, M B Edmond.   

Abstract

BACKGROUND: The incidence of bloodstream infection (BSI) varies according to the transplanted organ. Mortality can be as high as 24%, with a significant impact on graft survival. Transplantation is a risk factor for multidrug-resistant (MDR) organisms, but comparison with a non-transplanted population in a single large cohort has not been described.
METHODS: This is a prospective nationwide study (16 centers) reporting data on 2364 monomicrobial nosocomial BSIs, comparing 83 episodes in solid organ transplant patients with 2447 BSIs occurring in the general hospital population.
RESULTS: The prevalence of groups of infecting organisms (gram-positive, gram-negative, and fungi) was similar between transplant patients and the general population and a similar crude mortality rate was observed (34.9% in transplant vs. 43.3% in non-transplant patients). Staphylococcus aureus was the single most frequently isolated organism in both groups, and Acinetobacter species was more frequently isolated in the general population. Regarding MDR organisms, Klebsiella species, and Enterobacter species resistant to cefepime, as well as Acinetobacter species resistant to meropenem, were significantly more frequent in transplant patients.
CONCLUSION: Antimicrobial resistance is higher, particularly among gram-negative bacteria in the transplant population, although the overall mortality rate between transplant and non-transplant patients with nosocomial BSI is similar.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bloodstream infection; epidemiology; hospital; surveillance; transplantation

Mesh:

Year:  2015        PMID: 25726707     DOI: 10.1111/tid.12356

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  9 in total

Review 1.  Antibiotic Therapy for Difficult-to-Treat Infections in Lung Transplant Recipients: A Practical Approach.

Authors:  Lorena van den Bogaart; Oriol Manuel
Journal:  Antibiotics (Basel)       Date:  2022-05-02

2.  Inpatient Mortality Among Solid Organ Transplant Recipients Hospitalized for Sepsis and Severe Sepsis.

Authors:  John P Donnelly; Jayme E Locke; Paul A MacLennan; Gerald McGwin; Roslyn B Mannon; Monika M Safford; John W Baddley; Paul Muntner; Henry E Wang
Journal:  Clin Infect Dis       Date:  2016-05-23       Impact factor: 9.079

3.  The updated Charlson comorbidity index is a useful predictor of mortality in patients with Staphylococcus aureus bacteraemia.

Authors:  H G Ternavasio-de la Vega; F Castaño-Romero; S Ragozzino; R Sánchez González; M P Vaquero-Herrero; M Siller-Ruiz; G Spalter-Glicberg; C Ramírez-Baum; S Rodríguez-Rodríguez; J E García-Sánchez; I García-García; M Marcos
Journal:  Epidemiol Infect       Date:  2018-09-03       Impact factor: 4.434

Review 4.  Infectious Complications Following Solid Organ Transplantation.

Authors:  Alexis Guenette; Shahid Husain
Journal:  Crit Care Clin       Date:  2019-01       Impact factor: 3.598

Review 5.  Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients.

Authors:  Jean-François Timsit; Romain Sonneville; Andre C Kalil; Matteo Bassetti; Ricard Ferrer; Samir Jaber; Fanny Lanternier; Charles-Edouard Luyt; Flavia Machado; Malgorzata Mikulska; Laurent Papazian; Fréderic Pène; Garyphalia Poulakou; Claudio Viscoli; Michel Wolff; Lara Zafrani; Christian Van Delden
Journal:  Intensive Care Med       Date:  2019-03-25       Impact factor: 17.440

Review 6.  Extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches.

Authors:  Elena Pérez-Nadales; Mario Fernández-Ruiz; Belén Gutiérrez-Gutiérrez; Álvaro Pascual; Jesús Rodríguez-Baño; Luis Martínez-Martínez; José María Aguado; Julian Torre-Cisneros
Journal:  Transpl Infect Dis       Date:  2022-06-28

7.  Treatment of multidrug-resistant gram-negative bacilli after solid organ transplant: Outcomes and complications.

Authors:  Madeleine R Heldman; Kexin Guo; Brett Nelson; Tenzin Babu; Michael G Ison
Journal:  Transpl Infect Dis       Date:  2020-10-07

8.  Liver Transplantation and Gut Microbiota Profiling in a Child Colonized by a Multi-Drug Resistant Klebsiella pneumoniae: A New Approach to Move from Antibiotic to "Eubiotic" Control of Microbial Resistance.

Authors:  Federica Del Chierico; Sabrina Cardile; Andrea Pietrobattista; Daniela Liccardo; Alessandra Russo; Manila Candusso; Maria Sole Basso; Chiara Grimaldi; Laura Pansani; Paola Bernaschi; Giuliano Torre; Lorenza Putignani
Journal:  Int J Mol Sci       Date:  2018-04-25       Impact factor: 5.923

9.  Fungicidal Activity of a Safe 1,3,4-Oxadiazole Derivative Against Candida albicans.

Authors:  Daniella Renata Faria; Raquel Cabral Melo; Glaucia Sayuri Arita; Karina Mayumi Sakita; Franciele Abigail Vilugron Rodrigues-Vendramini; Isis Regina Grenier Capoci; Tania Cristina Alexandrino Becker; Patrícia de Souza Bonfim-Mendonça; Maria Sueli Soares Felipe; Terezinha Inez Estivalet Svidzinski; Erika Seki Kioshima
Journal:  Pathogens       Date:  2021-03-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.